January 2, 2026: Trulicity (Dulaglutide) May Be Safe for Use by Pregnant Women, Study Suggests Trulicity (dulaglutide) is used by many patients to control their diabetes
Lead Researcher Spotlight Professor Frank Ng, PhD Department of Biochemistry and Molecular Biology Monash University, Melbourne, Australia Professor Frank Ng led the pioneering research team that developed AOD-9604 in the 1990s as part of efforts to create a targeted anti-obesity therapeutic derived from human growth hormone
Insulin nasal spray: Insulin weighs approximately 5,800 daltons, larger than retatrutide
Some individuals notice subtle improvements within 24 weeks
Oxidative stress and endothelium influenced by Metformin in type 2 diabetes mellitus
Support initiatives within educational institutions and community settings aimed at destigmatizing obesity and informing families about available medical treatments